Adjuvant treatment after breast. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Breast Cell Line, Tumor Lymph Nodes Axilla Lower Gastrointestinal Tract Tumor Cells, Cultured Milk, Human Nipples MCF-7 Cells Mammary Glands, Human

Organisms3

Mice, Inbred BALB C Mice, Nude Mice, Inbred C57BL

Diseases58

Breast Neoplasms Carcinoma, Ductal, Breast Neoplasm Recurrence, Local Breast Diseases Lymphatic Metastasis Neoplasm Metastasis Colonic Neoplasms Neoplasm Invasiveness Adenocarcinoma Breast Neoplasms, Male Neoplasms, Hormone-Dependent Carcinoma, Lobular Fibrocystic Breast Disease Carcinoma Colorectal Neoplasms Rectal Neoplasms Neoplasms, Second Primary Sarcoma, Endometrial Stromal Melanoma Carcinoma, Intraductal, Noninfiltrating Recurrence Endometrial Neoplasms Lung Neoplasms Stomach Neoplasms Bone Neoplasms Pancreatic Neoplasms Gastrointestinal Stromal Tumors Skin Neoplasms Ovarian Neoplasms Disease Progression Sarcoma Bone Marrow Neoplasms Brain Neoplasms Giant Cell Tumor of Bone Breast Cyst Mammary Neoplasms, Experimental Soft Tissue Neoplasms Neoplasms Fibroadenoma Gastrointestinal Neoplasms Liver Neoplasms Seminoma Carcinoma, Ductal Neoplasm, Residual Carcinoma in Situ Disease Models, Animal Arthritis, Experimental Triple Negative Breast Neoplasms Testicular Neoplasms Carcinoma, Squamous Cell Inflammatory Breast Neoplasms Genetic Predisposition to Disease Uterine Neoplasms Carcinoma, Non-Small-Cell Lung Neutropenia Glioblastoma Urinary Bladder Neoplasms Kidney Neoplasms

Chemicals and Drugs67

Adjuvants, Immunologic Adjuvants, Pharmaceutic Tamoxifen Antineoplastic Agents, Hormonal Fluorouracil Freund's Adjuvant Receptors, Estrogen Levamisole Aromatase Inhibitors Antineoplastic Agents Receptor, erbB-2 Cyclophosphamide Receptors, Progesterone Leucovorin Tumor Markers, Biological Epirubicin Methotrexate Nitriles Triazoles Antimetabolites, Antineoplastic Anthracyclines Estrogen Antagonists Taxoids Antibodies, Monoclonal, Humanized Goserelin Organoplatinum Compounds Doxorubicin Aluminum Hydroxide Antibodies, Monoclonal Cisplatin Toremifene Aminoglutethimide Cancer Vaccines Ki-67 Antigen Deoxycytidine Antigens, Neoplasm Estrogen Receptor Modulators Antibiotics, Antineoplastic Mitomycin Neoplasm Proteins Interferon-alpha Antineoplastic Agents, Alkylating Carboplatin Estrogen Receptor alpha Estrogens Paclitaxel Vaccines Tumor Suppressor Protein p53 BRCA1 Protein BRCA2 Protein Recombinant Proteins Benzamides Selective Estrogen Receptor Modulators RNA, Messenger Androstadienes Receptor, Epidermal Growth Factor Vincristine Pyrimidines Vaccines, Subunit Immunoglobulin G Estradiol Piperazines Granulocyte Colony-Stimulating Factor DNA, Neoplasm Squalene Ovalbumin Saponins

Analytical, Diagnostic and Therapeutic Techniques and Equipment87

Chemotherapy, Adjuvant Radiotherapy, Adjuvant Disease-Free Survival Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Combined Modality Therapy Prognosis Survival Analysis Mastectomy Survival Rate Follow-Up Studies Retrospective Studies Randomized Controlled Trials as Topic Clinical Trials as Topic Neoadjuvant Therapy Kaplan-Meier Estimate Mammography Immunohistochemistry Lymph Node Excision Drug Administration Schedule Prospective Studies Risk Factors Mastectomy, Segmental Proportional Hazards Models Multivariate Analysis Breast Implants Breast Self-Examination Predictive Value of Tests Radiotherapy Cohort Studies Case-Control Studies Risk Assessment Multicenter Studies as Topic Postoperative Care Clinical Trials, Phase III as Topic Hysterectomy Ultrasonography, Mammary Gene Expression Profiling Immunotherapy, Active Brachytherapy Neoplasm Grading Patient Selection Immunotherapy Immunization SEER Program Infusions, Intravenous Sentinel Lymph Node Biopsy Radiotherapy Dosage Risk Incidence Tumor Burden Mammaplasty Digestive System Surgical Procedures Reverse Transcriptase Polymerase Chain Reaction Chemoradiotherapy, Adjuvant Odds Ratio Pancreatectomy Pilot Projects Mammary Neoplasms, Experimental Sensitivity and Specificity Double-Blind Method Administration, Oral Registries Random Allocation Administration, Intranasal Drug Therapy, Combination Cystectomy Analysis of Variance Breast Implantation Gastrectomy Mastectomy, Modified Radical Postoperative Period Questionnaires Logistic Models Disease Models, Animal Preoperative Care Research Design Arthritis, Experimental Feasibility Studies Biopsy, Needle Mass Screening Chi-Square Distribution Regression Analysis Mastectomy, Radical Vaccination Hepatectomy

Psychiatry and Psychology4

Breast Feeding Breast Self-Examination Patient Compliance Decision Making

Phenomena and Processes22

Breast Feeding Postmenopause Premenopause Time Factors Menopause Gene Expression Regulation, Neoplastic Genes, BRCA1 Risk Odds Ratio Dose-Response Relationship, Drug Sensitivity and Specificity Cell Proliferation Genes, erbB-2 Apoptosis Genes, BRCA2 Mutation Drug Resistance, Neoplasm Antibody Formation Genetic Predisposition to Disease Chi-Square Distribution Signal Transduction Immunity, Mucosal

Disciplines and Occupations4

Immunohistochemistry Medical Oncology Research Design Evidence-Based Medicine

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science5

Survival Rate SEER Program Incidence Registries Questionnaires

Named Groups1

Health Care46

Disease-Free Survival Treatment Outcome Survival Analysis Survival Rate Follow-Up Studies Retrospective Studies Randomized Controlled Trials as Topic Clinical Trials as Topic Kaplan-Meier Estimate Prospective Studies Risk Factors Proportional Hazards Models Multivariate Analysis Predictive Value of Tests Age Factors Cohort Studies Case-Control Studies Risk Assessment Multicenter Studies as Topic Postoperative Care Clinical Trials, Phase III as Topic Cost-Benefit Analysis Patient Selection Immunization SEER Program Risk Incidence Odds Ratio Pilot Projects Sensitivity and Specificity Double-Blind Method Registries Random Allocation Analysis of Variance Postoperative Period Questionnaires Logistic Models Preoperative Care Feasibility Studies Mass Screening Chi-Square Distribution Patient Compliance Regression Analysis Vaccination Physician's Practice Patterns Practice Guidelines as Topic

Geographicals2

United States Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Health Care Geographicals

Chemotherapy, Adjuvant Breast Adjuvants, Immunologic Radiotherapy, Adjuvant Adjuvants, Pharmaceutic Tamoxifen Breast Neoplasms Carcinoma, Ductal, Breast Antineoplastic Agents, Hormonal Disease-Free Survival Neoplasm Recurrence, Local Neoplasm Staging Breast Diseases Fluorouracil Freund's Adjuvant Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Combined Modality Therapy Prognosis Lymphatic Metastasis Receptors, Estrogen Levamisole Survival Analysis Aromatase Inhibitors Mastectomy Antineoplastic Agents Receptor, erbB-2 Survival Rate Cyclophosphamide Follow-Up Studies Breast Feeding Receptors, Progesterone Postmenopause Leucovorin Retrospective Studies Tumor Markers, Biological Neoplasm Metastasis Colonic Neoplasms Randomized Controlled Trials as Topic Premenopause Neoplasm Invasiveness Adenocarcinoma Epirubicin Methotrexate Nitriles Clinical Trials as Topic Time Factors Triazoles Cell Line, Tumor Breast Neoplasms, Male Neoadjuvant Therapy Neoplasms, Hormone-Dependent Kaplan-Meier Estimate Lymph Nodes Mammography Immunohistochemistry Lymph Node Excision Drug Administration Schedule Axilla Prospective Studies Carcinoma, Lobular Risk Factors Mastectomy, Segmental Proportional Hazards Models Fibrocystic Breast Disease Menopause Multivariate Analysis Gene Expression Regulation, Neoplastic Antimetabolites, Antineoplastic Medical Oncology Carcinoma Anthracyclines Breast Implants Colorectal Neoplasms Estrogen Antagonists Taxoids Antibodies, Monoclonal, Humanized Breast Self-Examination Goserelin Rectal Neoplasms Organoplatinum Compounds Neoplasms, Second Primary Predictive Value of Tests Sarcoma, Endometrial Stromal Age Factors Radiotherapy Cohort Studies Doxorubicin Melanoma Carcinoma, Intraductal, Noninfiltrating Case-Control Studies Recurrence Risk Assessment Quality of Life Aluminum Hydroxide Mice, Inbred BALB C Antibodies, Monoclonal Endometrial Neoplasms Lung Neoplasms Cisplatin

No FAQ available that match "adjuvant treatment after breast"